• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗生素治疗的时机:何时开始、何时降级以及何时停止抗生素治疗。来自既定抗菌药物管理计划的建议。

Timing in antibiotic therapy: when and how to start, de-escalate and stop antibiotic therapy. Proposals from a stablished antimicrobial stewardship program.

机构信息

Juan Pasquau, Servicio de Enfermedades Infecciosas. Hospital Universitario Virgen de la Nieves, Granada, Spain.

出版信息

Rev Esp Quimioter. 2022 Oct;35 Suppl 3(Suppl 3):102-107. doi: 10.37201/req/s03.22.2022. Epub 2022 Oct 24.

DOI:10.37201/req/s03.22.2022
PMID:36285869
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9717451/
Abstract

The current morbimortality of serious infections is unacceptable and there is a need to promote the increase in the efficacy of empirical and targeted antibiotherapy. This could be achieved by initiatives coming from ASP teams aimed at promoting increased efficacy of antibiotic therapy .In the optimization of the antibiotic therapy there are several critical points in which an adequate timing could achieve benefits in the survival of patients with severe infections: prompt initiation of empirical treatment; de-escalation performance, appropriate targeted treatment; and finally, curtail antibiotic duration.

摘要

目前严重感染的发病率和死亡率是不可接受的,需要提高经验性和靶向抗生素治疗的疗效。这可以通过 ASP 团队的举措来实现,旨在提高抗生素治疗的疗效。在优化抗生素治疗中,有几个关键要点,如果时机得当,可以提高严重感染患者的生存率:及时启动经验性治疗;降级治疗、适当的靶向治疗;最后,缩短抗生素使用时间。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce47/9717451/15fba9ee3175/revespquimioter-35-suppl-3-102-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce47/9717451/15fba9ee3175/revespquimioter-35-suppl-3-102-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce47/9717451/15fba9ee3175/revespquimioter-35-suppl-3-102-g001.jpg

相似文献

1
Timing in antibiotic therapy: when and how to start, de-escalate and stop antibiotic therapy. Proposals from a stablished antimicrobial stewardship program.抗生素治疗的时机:何时开始、何时降级以及何时停止抗生素治疗。来自既定抗菌药物管理计划的建议。
Rev Esp Quimioter. 2022 Oct;35 Suppl 3(Suppl 3):102-107. doi: 10.37201/req/s03.22.2022. Epub 2022 Oct 24.
2
Acceptance and outcome of interventions in a meropenem de-escalation antimicrobial stewardship program in pediatrics.儿科美罗培南降阶梯抗菌药物管理项目中干预措施的接受情况和结局。
Pediatr Int. 2021 Dec;63(12):1458-1465. doi: 10.1111/ped.14703. Epub 2021 Nov 21.
3
Antibiotics: easier to start than to stop? Predictors of antimicrobial stewardship recommendation acceptance.抗生素:开始容易,停止难?抗菌药物管理推荐接受的预测因素。
Clin Microbiol Infect. 2020 Dec;26(12):1638-1643. doi: 10.1016/j.cmi.2020.07.048. Epub 2020 Aug 6.
4
How Antibiotics Stewardship Can Be Safely Implemented in Patients with Septic Shock?如何在感染性休克患者中安全实施抗生素管理?
Semin Respir Crit Care Med. 2021 Oct;42(5):689-697. doi: 10.1055/s-0041-1733987. Epub 2021 Sep 20.
5
Design and analysis of a pharmacist-enhanced antimicrobial stewardship program in Thailand.泰国药剂师强化抗菌药物管理计划的设计与分析
Am J Infect Control. 2015 Sep 1;43(9):956-9. doi: 10.1016/j.ajic.2015.05.011. Epub 2015 Jun 19.
6
Antibiotic Use in the Intensive Care Unit: Optimization and De-Escalation.抗生素在重症监护病房的应用:优化与降级。
J Intensive Care Med. 2018 Dec;33(12):647-655. doi: 10.1177/0885066618762747. Epub 2018 Mar 13.
7
Development of an Electronic Definition for De-escalation of Antibiotics in Hospitalized Patients.制定住院患者抗生素降阶梯治疗的电子定义。
Clin Infect Dis. 2021 Dec 6;73(11):e4507-e4514. doi: 10.1093/cid/ciaa932.
8
Antibiotic strategies in severe nosocomial sepsis: why do we not de-escalate more often?严重医院获得性脓毒症的抗生素策略:为什么我们不更经常降级治疗?
Crit Care Med. 2012 May;40(5):1404-9. doi: 10.1097/CCM.0b013e3182416ecf.
9
Antimicrobial Stewardship in the ICU.重症监护病房中的抗菌药物管理
Semin Respir Crit Care Med. 2022 Feb;43(1):131-140. doi: 10.1055/s-0041-1740977. Epub 2022 Feb 16.
10
Frequency of empiric antibiotic de-escalation in an acute care hospital with an established Antimicrobial Stewardship Program.在一家设有抗菌药物管理项目的急症医院中经验性抗生素降阶梯治疗的频率。
BMC Infect Dis. 2016 Dec 12;16(1):751. doi: 10.1186/s12879-016-2080-3.

引用本文的文献

1
Propensity-Matched Comparison of Timely vs Delayed Antibiotic Therapy in Pneumonia.肺炎中及时与延迟抗生素治疗的倾向评分匹配比较
Open Forum Infect Dis. 2025 Aug 7;12(8):ofaf469. doi: 10.1093/ofid/ofaf469. eCollection 2025 Aug.
2
Antimicrobial stewardship reduces antibiotic use density and cost in a Chinese tertiary hospital.抗菌药物管理降低了中国一家三级医院的抗生素使用密度和成本。
Sci Rep. 2025 Jul 2;15(1):23609. doi: 10.1038/s41598-025-06622-5.
3
Empiric and targeted antibiotic therapy for bloodstream infections in internal medicine patients in Poland: a three-year analysis in a single centre using the AWaRe classification.

本文引用的文献

1
[New predictive models of bacteremia in the emergency department: a step forward].[急诊科菌血症的新预测模型:向前迈进的一步]
Rev Esp Quimioter. 2022 Aug;35(4):344-356. doi: 10.37201/req/015.2022. Epub 2022 Apr 13.
2
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.2019 年全球细菌对抗菌药物耐药性的负担:系统分析。
Lancet. 2022 Feb 12;399(10325):629-655. doi: 10.1016/S0140-6736(21)02724-0. Epub 2022 Jan 19.
3
Impact of Empirical Antibiotic Regimens on Mortality in Neutropenic Patients with Bloodstream Infection Presenting with Septic Shock.
波兰内科患者血流感染的经验性和针对性抗生素治疗:在单一中心使用AWaRe分类法进行的三年分析
Pharmacol Rep. 2025 Jun 19. doi: 10.1007/s43440-025-00753-2.
4
Antimicrobial stewardship interventions reduce the time to the first antibiotic administration in septic patients in ICUs: regional multicenter study in 7 Latin American high-complexity hospitals.抗菌药物管理干预措施可缩短重症监护病房脓毒症患者首次使用抗生素的时间:拉丁美洲7家高复杂性医院的区域多中心研究
Antimicrob Agents Chemother. 2025 Aug 6;69(8):e0185024. doi: 10.1128/aac.01850-24. Epub 2025 Jun 17.
5
The antibiotic de-escalation strategy in patients with multidrug-resistant bacterial colonization after allogeneic stem cell transplantation.异基因干细胞移植后多重耐药菌定植患者的抗生素降阶梯策略
Front Microbiol. 2025 Jan 3;15:1487617. doi: 10.3389/fmicb.2024.1487617. eCollection 2024.
6
The importance of antibiotic treatment duration in antimicrobial resistance.抗生素治疗时间长短对抗微生物耐药性的重要性。
Eur J Clin Microbiol Infect Dis. 2024 Aug;43(8):1673-1675. doi: 10.1007/s10096-024-04867-y. Epub 2024 Jun 4.
7
Impact of Antimicrobial Stewardship on Reducing Antimicrobial Resistance.抗菌药物管理对降低抗菌药物耐药性的影响。
Cureus. 2023 Dec 4;15(12):e49935. doi: 10.7759/cureus.49935. eCollection 2023 Dec.
8
The Challenge of Bacteremia Treatment due to Non-Fermenting Gram-Negative Bacteria.非发酵革兰氏阴性菌所致菌血症的治疗挑战
Microorganisms. 2023 Mar 30;11(4):899. doi: 10.3390/microorganisms11040899.
经验性抗生素治疗方案对伴有感染性休克的中性粒细胞减少症血流感染患者死亡率的影响。
Antimicrob Agents Chemother. 2022 Feb 15;66(2):e0174421. doi: 10.1128/AAC.01744-21. Epub 2021 Nov 29.
4
Recommendations for antibiotic selection for severe nosocomial infections.严重医院获得性感染的抗生素选择建议。
Rev Esp Quimioter. 2021 Oct;34(5):511-524. doi: 10.37201/req/126.2021. Epub 2021 Oct 25.
5
Comparative Effectiveness of Switching to Daptomycin Versus Remaining on Vancomycin Among Patients With Methicillin-resistant Staphylococcus aureus (MRSA) Bloodstream Infections.比较耐甲氧西林金黄色葡萄球菌(MRSA)血流感染患者换用达托霉素与继续使用万古霉素的疗效。
Clin Infect Dis. 2021 Jan 29;72(Suppl 1):S68-S73. doi: 10.1093/cid/ciaa1572.
6
Inappropriate empirical antibiotic therapy for bloodstream infections based on discordant in-vitro susceptibilities: a retrospective cohort analysis of prevalence, predictors, and mortality risk in US hospitals.基于体外药敏结果不一致的血流感染经验性抗生素治疗不当:美国医院的患病率、预测因素和死亡风险的回顾性队列分析。
Lancet Infect Dis. 2021 Feb;21(2):241-251. doi: 10.1016/S1473-3099(20)30477-1. Epub 2020 Sep 8.
7
Mortality in sepsis and septic shock in Europe, North America and Australia between 2009 and 2019- results from a systematic review and meta-analysis.2009 年至 2019 年期间欧洲、北美和澳大利亚脓毒症和脓毒性休克患者的死亡率:系统评价和荟萃分析的结果。
Crit Care. 2020 May 19;24(1):239. doi: 10.1186/s13054-020-02950-2.
8
Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study.全球、地区和国家脓毒症发病率和死亡率,1990-2017 年:全球疾病负担研究分析。
Lancet. 2020 Jan 18;395(10219):200-211. doi: 10.1016/S0140-6736(19)32989-7.
9
Monotherapy versus combination therapy for multidrug-resistant Gram-negative infections: Systematic Review and Meta-Analysis.单药治疗与联合治疗多重耐药革兰氏阴性感染:系统评价和荟萃分析。
Sci Rep. 2019 Oct 29;9(1):15290. doi: 10.1038/s41598-019-51711-x.
10
Inappropriate Empirical Antibiotic Treatment in High-risk Neutropenic Patients With Bacteremia in the Era of Multidrug Resistance.多重耐药时代高危中性粒细胞减少血症合并菌血症患者的不适当经验性抗生素治疗。
Clin Infect Dis. 2020 Mar 3;70(6):1068-1074. doi: 10.1093/cid/ciz319.